Average Co-Inventor Count = 2.72
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G1 Therapeutics, Inc. (5 from 48 patents)
2. Fennec Pharmaceuticals, Inc. (3 from 7 patents)
3. Akebia Therapeutics, Inc. (2 from 32 patents)
4. Pharmacosmos Holding A/s (2 from 25 patents)
5. Aerpio Therapeutics, Inc. (1 from 35 patents)
6. Eyepoint Pharmaceuticals, Inc. (1 from 19 patents)
7. Gi Therapeutics, Inc. (1 from 8 patents)
8. Fennec Pharnceuticals Inc. (1 from 1 patent)
16 patents:
1. 12497404 - Morphic forms of trilaciclib and methods of manufacture thereof
2. 12479855 - Morphic forms of trilaciclib and methods of manufacture thereof
3. 12311026 - Therapeutic uses for sodium thiosulfate formulations
4. 12168666 - Morphic forms of trilaciclib and methods of manufacture thereof
5. 12152023 - Compositions, formulations and methods for treating ocular diseases
6. 12139494 - Morphic forms of G1T38 and methods of manufacture thereof
7. 11998604 - Therapeutic uses for sodium thiosulfate formulations
8. 11992530 - Therapeutic uses for sodium thiosulfate and formulations
9. 11964018 - Therapeutic uses for sodium thiosulfate formulations
10. 11844756 - Compositions and methods for treating anemia
11. 11629150 - Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
12. 11324734 - Compositions and methods for treating anemia
13. 11261193 - Morphic forms of G1T38 and methods of manufacture thereof
14. 10988479 - Morphic forms of trilaciclib and methods of manufacture thereof
15. 10865210 - Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines